{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:33:45Z","timestamp":1791218025845,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.amjcard.2005.12.029","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T15:41:59Z","timestamp":1149176519000},"page":"71-76","source":"Crossref","is-referenced-by-count":100,"special_numbering":"S1","title":["Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids"],"prefix":"10.1016","volume":"98","author":[{"given":"Harold","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.12.029_bib1","unstructured":"American Heart Association. Fish and omega-3 fatty acids [AHA Recommendation]. Available at: http:\/\/www.americanheart.org\/presenter.jhtml?identifier=4632. Accessed January 27, 2006."},{"key":"10.1016\/j.amjcard.2005.12.029_bib2","unstructured":"United States Department of Agriculture, Agricultural Research Service Nutrient Data Laboratory. Available at: http:\/\/www.nal.usda.gov\/fnic\/foodcomp\/search\/. Accessed January 27, 2006."},{"key":"10.1016\/j.amjcard.2005.12.029_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.12.029_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2796.1995.tb01173.x","article-title":"Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia","volume":"237","author":"Grundt","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjcard.2005.12.029_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9149(97)89130-8","article-title":"Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency","volume":"77","author":"Eritsland","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.12.029_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00043798-199710000-00011","article-title":"Safety and efficacy of Omacor in severe hypertriglyceridemia","volume":"4","author":"Harris","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.amjcard.2005.12.029_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-2275(20)37251-5","article-title":"Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia","volume":"38","author":"McKeone","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.amjcard.2005.12.029_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.ATV.18.5.723","article-title":"Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion","volume":"18","author":"Abe","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.12.029_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(98)00301-3","article-title":"Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins","volume":"143","author":"Pownall","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.12.029_bib10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0735-1097(99)00054-6","article-title":"N-3 fatty acids do not prevent restenosis after coronary angioplasty","volume":"33","author":"Johansen","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.12.029_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(99)00267-1","article-title":"Omacor in familial combined hyperlipidemia","volume":"148","author":"Calabresi","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.12.029_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajcn\/71.4.914","article-title":"Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids","volume":"71","author":"Westphal","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.amjcard.2005.12.029_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(00)00381-6","article-title":"The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia","volume":"153","author":"Stalenhoef","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.12.029_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/heart.85.5.544","article-title":"An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia","volume":"85","author":"Durrington","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2005.12.029_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.metabol.2003.09.007","article-title":"An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia","volume":"53","author":"Calabresi","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.amjcard.2005.12.029_bib16","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V81.7.1871.1871","article-title":"Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells","volume":"81","author":"Kaminski","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2005.12.029_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/00365519509104966","article-title":"Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation","volume":"55","author":"Eritsland","year":"1995","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.amjcard.2005.12.029_bib18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199512010-00059","article-title":"Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension","volume":"13","author":"Russo","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjcard.2005.12.029_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1681\/ASN.V124791","article-title":"A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy","volume":"12","author":"Donadio","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2005.12.029_bib20","unstructured":"US Department of Health and Human Resources and the US Environmental Protection Agency. What you need to know about mercury in fish and shellfish: 2004 EPA and FDA advice for: women who might become pregnant, women who are pregnant, nursing mothers, young children. Publication No. EPA-823-R-04-005. Available at: http:\/\/www.cfsan.fda.gov\/\u223cdms\/admehg3.html. Accessed January 27, 2006."},{"key":"10.1016\/j.amjcard.2005.12.029_bib21","unstructured":"Solvay Healthcare Limited. Omacor Production. Solvay Public Omacor Website. Available at: http:\/\/www.Omacor.co.uk\/pages\/dykproduction.asp. Accessed January 27, 2006."},{"key":"10.1016\/j.amjcard.2005.12.029_bib22","unstructured":"Omacor [prescribing information]. Liberty Corner, NJ: Reliant Pharmaceuticals, Inc; 2005. Available at: http:\/\/www.omacorrx.com\/OMACOR\/OMACOR_Prescribing_Information.pdf. Accessed April 7, 2006."}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905021922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905021922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T18:42:22Z","timestamp":1627411342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905021922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002914905021922"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.029","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}